Developmental effects of SSRIs: lessons learned from animal studies

International Journal of Developmental Neuroscience

Volumn 25, Issue 6, 2007, Pages 341-347

  Borue, Xenia ^a   Chen, John ^a   Condron, Barry G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

CNS development; Neurotransmitter; Serotonin

Indexed keywords

DOPAMINE; HISTAMINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; VESICULAR MONOAMINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD PLACENTA BARRIER; BREAST FEEDING EDUCATION; CONTROLLED STUDY; DEPRESSION; DEVELOPMENTAL DISORDER; DRUG RESEARCH; FETOPLACENTAL UNIT; GENETIC POLYMORPHISM; LACTATION; NONHUMAN; POSTNATAL DEVELOPMENT; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; REVIEW; SEROTONIN RELEASE; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MONOAMINE OXIDASE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC TRANSMISSION;

ANIMALIA; RODENTIA;

EID: 35748972688     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2007.06.003     Document Type: Review

References (62)

1. Alexandre C., Popa D., Fabre V., Bouali S., Venault P., Lesch K.P., Hamon M., and Adrien J. Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J. Neurosci. 26 (2006) 5554-5564
2. Ansorge M.S., Zhou M., Lira A., Hen R., and Gingrich J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306 (2004) 879-881
3. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
4. Beltz B.S., Benton J.L., and Sullivan J.M. Transient uptake of serotonin by newborn olfactory projection neurons. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12730-12735
5. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., Mossner R., Westphal H., and Lesch K.P. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol. Pharmacol. 53 (1998) 649-655
6. Bennett-Clarke C.A., Hankin M.H., Leslie M.J., Chiaia N.L., and Rhoades R.W. Patterning of the neocortical projections from the raphe nuclei in perinatal rats: investigation of potential organizational mechanisms. J. Comp. Neurol. 348 (1994) 277-290
7. Boylan C.B., Blue M.E., and Hohmann C.F. Modeling early cortical serotonergic deficits in autism. Behav. Brain Res. (2006)
8. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., Mcclay J., Mill J., Martin J., Braithwaite A., and Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003) 386-389
9. Condron B.G. Serotonergic neurons transiently require a midline-derived FGF signal. Neuron 24 (1999) 531-540
10. Couch J.A., Chen J., Rieff H.I., Uri E.M., and Condron B.G. Robo2 and robo3 interact with eagle to regulate serotonergic neuron differentiation. Development 131 (2004) 997-1006
11. D'amato R.J., Blue M.E., Largent B.L., Lynch D.R., Ledbetter D.J., Molliver M.E., and Snyder S.H. Ontogeny of the serotonergic projection to rat neocortex: transient expression of a dense innervation to primary sensory areas. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 4322-4326
12. Drugs C.O. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Committee on Drugs 105 (2000), American Academy of Pediatrics, Pediatrics 880-887
13. Du L., Bakish D., Ravindran A., and Hrdina P.D. MAO-A gene polymorphisms are associated with major depression and sleep disturbance in males. Neuroreport 15 (2004) 2097-2101
14. Evans S.J., Choudary P.V., Neal C.R., Li J.Z., Vawter M.P., Tomita H., Lopez J.F., Thompson R.C., Meng F., Stead J.D., Walsh D.M., Myers R.M., Bunney W.E., Watson S.J., Jones E.G., and Akil H. Dysregulation of the fibroblast growth factor system in major depression. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 15506-15511
15. Gaspar P., Cases O., and Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 4 (2003) 1002-1012
16. Glanzman D.L. Postsynaptic regulation of the development and long-term plasticity of Aplysia sensorimotor synapses in cell culture. J. Neurobiol. 25 (1994) 666-693
17. Groenink L., Van Bogaert M.J., Van Der Gugten J., Oosting R.S., and Olivier B. 5-HT1A receptor and 5-HT1B receptor knockout mice in stress and anxiety paradigms. Behav. Pharmacol. 14 (2003) 369-383
18. Hahn M.K., and Blakely R.D. Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenomics J. 2 (2002) 217-235
19. Hansen H.H., and Mikkelsen J.D. Long-term effects on serotonin transporter mRNA expression of chronic neonatal exposure to a serotonin reuptake inhibitor. Eur. J. Pharmacol. 352 (1998) 307-315
20. Hansen H.H., Sanchez C., and Meier E. Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression?. J. Pharmacol. Exp. Ther. 283 (1997) 1333-1341
21. Hen R. Structural and functional conservation of serotonin receptors throughout evolution. EXS 63 (1993) 266-278
22. Hendrick V., Stowe Z.N., Altshuler L.L., Hwang S., Lee E., and Haynes D. Placental passage of antidepressant medications. Am. J. Psychiatry 160 (2003) 993-996
23. Hendricks T.J., Fyodorov D.V., Wegman L.J., Lelutiu N.B., Pehek E.A., Yamamoto B., Silver J., Weeber E.J., Sweatt J.D., and Deneris E.S. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 37 (2003) 233-247
24. Hohmann C.F., Richardson C., Pitts E., and Berger-Sweeney J. Neonatal 5,7-DHT lesions cause sex-specific changes in mouse cortical morphogenesis. Neural Plast. 7 (2000) 213-232
25. Hohmann C.F., Walker E.M., Boylan C.B., and Blue M.E. Neonatal serotonin depletion alters behavioral responses to spatial change and novelty. Brain Res. 1139 (2007) 163-177
26. Holmes A., Lit Q., Murphy D.L., Gold E., and Crawley J.N. Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav. 2 (2003) 365-380
27. Holmes A., Murphy D.L., and Crawley J.N. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol. Psychiatry 54 (2003) 953-959
28. Holmes A., Yang R.J., Lesch K.P., Crawley J.N., and Murphy D.L. Mice lacking the serotonin transporter Exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 28 (2003) 2077-2088
29. Janusonis S., Gluncic V., and Rakic P. Early serotonergic projections to Cajal-Retzius cells: relevance for cortical development. J. Neurosci. 24 (2004) 1652-1659
30. Kahne D., Tudorica A., Borella A., Shapiro L., Johnstone F., Huang W., and Whitaker-Azmitia P.M. Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. Physiol. Behav. 75 (2002) 403-410
31. Kim D.K., Tolliver T.J., Huang S.J., Martin B.J., Andrews A.M., Wichems C., Holmes A., Lesch K.P., and Murphy D.L. Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49 (2005) 798-810
32. Lasky-Su J.A., Faraone S.V., Glatt S.J., and Tsuang M.T. Meta-analysis of the association between two polymorphisms in the serotonin transporter gene and affective disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 133 (2005) 110-115
33. Lebrand C., Cases O., Adelbrecht C., Doye A., Alvarez C., El Mestikawy S., Seif I., and Gaspar P. Transient uptake and storage of serotonin in developing thalamic neurons. Neuron 17 (1996) 823-835
34. Li Q. Cellular and molecular alterations in mice with deficient and reduced serotonin transporters. Mol. Neurobiol. 34 (2006) 51-66
35. Li X.M., Perry K.W., and Wong D.T. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine. Chin. J. Physiol. 42 (1999) 53-59
36. Lira A., Zhou M., Castanon N., Ansorge M.S., Gordon J.A., Francis J.H., Bradley-Moore M., Lira J., Underwood M.D., Arango V., Kung H.F., Hofer M.A., Hen R., and Gingrich J.A. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 54 (2003) 960-971
37. Lucki I., Dalvi A., and Mayorga A.J. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 155 (2001) 315-322
38. Luhmann H.J., Hanganu I., and Kilb W. Cellular physiology of the neonatal rat cerebral cortex. Brain Res. Bull. 60 (2003) 345-353
39. Maciag D., Simpson K.L., Coppinger D., Lu Y., Wang Y., Lin R.C., and Paul I.A. Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 31 (2006) 47-57
40. Maron E., Toru I., Must A., Tasa G., Toover E., Vasar V., Lang A., and Shlik J. Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder. Neurosci Lett 411 (2007) 180-184
41. Mathews T.A., Fedele D.E., Coppelli F.M., Avila A.M., Murphy D.L., and Andrews A.M. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J. Neurosci. Methods 140 (2004) 169-181
42. Meyer-Lindenberg A., Buckholtz J.W., Kolachana B.A.R.H., Pezawas L., Blasi G., Wabnitz A., Honea R., Verchinski B., Callicott J.H., Egan M., Mattay V., and Weinberger D.R. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 6269-6274
43. Mirmiran M., Van De Poll N.E., Corner M.A., Van Oyen H.G., and Bour H.L. Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: effects upon adult sleep and behavior in the rat. Brain Res. 204 (1981) 129-146
44. Montanez S., Owens W.A., Gould G.G., Murphy D.L., and Daws L.C. Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. J. Neurochem. 86 (2003) 210-219
45. Murphy D.L., Li Q., Engel S., Wichems C., Andrews A., Lesch K.P., and Uhl G. Genetic perspectives on the serotonin transporter. Brain Res. Bull. 56 (2001) 487-494
46. Murphy D.L., Lerner A., Rudnick G., and Lesch K.P. Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol. Interv. 4 (2004) 109-123
47. Ogawa M., Miyata T., Nakajima K., Yagyu K., Seike M., Ikenaka K., Yamamoto H., and Mikoshiba K. The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neuron 14 (1995) 899-912
48. Persico A.M., Altamura C., Calia E., Puglisi-Allegra S., Ventura R., Lucchese F., and Keller F. Serotonin depletion and barrel cortex development: impact of growth impairment vs. serotonin effects on thalamocortical endings. Cereb. Cortex 10 (2000) 181-191
49. Persico A.M., Mengual E., Moessner R., Hall F.S., Revay R.S., Sora I., Arellano J., Defelipe J., Gimenez-Amaya J.M., Conciatori M., Marino R., Baldi A., Cabib S., Pascucci T., Uhl G.R., Murphy D.L., Lesch K.P., and Keller F. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J. Neurosci. 21 (2001) 6862-6873
50. Prathiba J., Kumar K.B., and Karanth K.S. Hyperactivity of hypothalamic pituitary axis in neonatal clomipramine model of depression. J. Neural. Transm. 105 (1998) 1335-1339
51. Rebsam A., Seif I., and Gaspar P. Refinement of thalamocortical arbors and emergence of barrel domains in the primary somatosensory cortex: a study of normal and monoamine oxidase a knock-out mice. J. Neurosci. 22 (2002) 8541-8552
52. Salichon N., Gaspar P., Upton A.L., Picaud S., Hanoun N., Hamon M., De Maeyer E., Murphy D.L., Mossner R., Lesch K.P., Hen R., and Seif I. Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-HT transporter knock-out mice. J. Neurosci. 21 (2001) 884-896
53. Thakker D.R., Natt F., Husken D., Van Der Putten H., Maier R., Hoyer D., and Cryan J.F. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Mol. Psychiatry 10 782-789 (2005) 714
54. Tjurmina O.A., Armando I., Saavedra J.M., Goldstein D.S., and Murphy D.L. Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology 143 (2002) 4520-4526
55. Upton A.L., Salichon N., Lebrand C., Ravary A., Blakely R., Seif I., and Gaspar P. Excess of serotonin (5-HT) alters the segregation of ispilateral and contralateral retinal projections in monoamine oxidase A knock-out mice: possible role of 5-HT uptake in retinal ganglion cells during development. J. Neurosci. 19 (1999) 7007-7024
56. Vitalis T., and Parnavelas J.G. The role of serotonin in early cortical development. Dev. Neurosci. 25 (2003) 245-256
57. Wang Y.M., Gainetdinov R.R., Fumagalli F., Xu F., Jones S.R., Bock C.B., Miller G.W., Wightman R.M., and Caron M.G. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19 (1997) 1285-1296
58. Weissman A.M., Levy B.T., Hartz A.J., Bentler S., Donohue M., Ellingrod V.L., and Wisner K.L. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am. J. Psychiatry 161 (2004) 1066-1078
59. Whitaker-Azmitia P.M. Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?. Int. J. Dev. Neurosci. 23 (2005) 75-83
60. Xu Y., Sari Y., and Zhou F.C. Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development. Brain Res. Dev. Brain Res. 150 (2004) 151-161
61. Zhou F.M., Liang Y., Salas R., Zhang L., De Biasi M., and Dani J.A. Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron 46 (2005) 65-74
62. Zill P., Buttner A., Eisenmenger W., Moller H.J., Bondy B., and Ackenheil M. Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol. Psychiatry 56 (2004) 581-586